Multiple Myeloma Market
The multiple myeloma market size is projected to reach $53,521.76 million by 2031, registering a CAGR of 10.5% from 2022 to 2031.
PORTLAND, OREGON, UNITED STATES, July 11, 2023/EINPresswire.com/ — The multiple myeloma market size was valued at $19,666.74 million in 2021, and is projected to reach $53,521.76 million by 2031, registering a CAGR of 10.5% from 2022 to 2031.
Multiple myeloma is a form of cancer that impacts plasma cells, a specific type of white blood cell crucial for defending against infections. This condition leads to the creation of abnormal proteins known as paraproteins, which can accumulate in the body and harm organs and tissues. Common symptoms of multiple myeloma encompass bone pain, anemia, recurring infections, and kidney complications. Available treatment options involve chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐- https://www.alliedmarketresearch.com/request-sample/3725
The global multiple myeloma market is driven by several key factors, including the increasing focus on research and development activities in the field of cancer treatment and the rapid introduction of new medications with regulatory approvals. The market has been positively influenced by the advent of monoclonal antibodies (mAbs) such as Empliciti and Darzalex, which have made significant contributions to its growth. A noteworthy example is the FDA approval in March 2020 of Sarclisa (isatuximab-irfc) by Sanofi, a prominent multinational pharmaceutical and healthcare company. Sarclisa, in combination with pomalidomide and dexamethasone (pom-dex), was approved for the treatment of adults with relapsed refractory multiple myeloma (RRMM). This development has further propelled the expansion of the global multiple myeloma market.
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
Which region has more opportunities?
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (411+ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ: https://www.alliedmarketresearch.com/multiple-myeloma-market/purchase-options
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ ๐
๐จ๐ซ ๐๐ญ๐๐ค๐๐ก๐จ๐ฅ๐๐๐ซ๐ฌ
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multiple myeloma market analysis from 2021 to 2031 to identify the prevailing multiple myeloma market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the multiple myeloma market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global multiple myeloma market trends, key players, market segments, application areas, and market growth strategies.
๐๐๐ฏ๐ ๐๐ง๐ฒ ๐๐ฎ๐๐ซ๐ฒ? ๐๐ฌ๐ค ๐๐ฎ๐ซ ๐๐ฑ๐ฉ๐๐ซ๐ญ @: https://www.alliedmarketresearch.com/purchase-enquiry/3725
๐๐จ๐ฉ ๐๐ฎ๐ฅ๐ญ๐ข๐ฉ๐ฅ๐ ๐๐ฒ๐๐ฅ๐จ๐ฆ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
Sanofi
Takeda Pharmaceutical Company Ltd
AbbVie Inc
Pfizer Inc.
Novartis AG
Baxter International Inc.
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries
Johnson & Johnson
Amgen Inc.
๐๐๐ฒ ๐๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐ฌ๐ญ๐ฎ๐๐ฒ
โข By drug type, the protease inhibitor segment dominated the market in 2021.
โข On the basis of disease type, the active multiple myeloma segment led the market in 2021.
โข Depending on end user, hospitals was the prominent segment in 2021.
โข Region wise, North America exhibited the highest growth in 2021, and is expected to grow during the forecast period.
๐๐จ๐ฉ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐ข๐๐ ๐๐๐ข๐๐ง๐๐ ๐๐จ๐ฆ๐๐ข๐ง-
๐๐๐ฌ๐ญ๐ซ๐ข๐ ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/gastric-cancer-market-A74458
๐๐ฅ๐จ๐จ๐ ๐๐ซ๐๐ฌ๐ฌ๐ฎ๐ซ๐ ๐๐ฎ๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/blood-pressure-cuffs-market-A11934
๐๐จ๐ข๐ง๐ญ ๐๐๐ข๐ง ๐๐ง๐ฃ๐๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/joint-pain-injections-market-A31459
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
